Identification of external critical success factors in biotechnology firms

Article Sidebar

PDF HTML
Published: Jan 1, 2014
DOI: https://doi.org/10.14807/ijmp.v5i1.138
Keywords:
Biotechnology External Success Factors Iran

Main Article Content

Abdolreza Gholamali
University of Tehran
Dariush Abbasi
Islamic Azad University, Tehran
Sima Sarafi Zanjani
Islamic Azad University, Tehran

Abstract

Biotechnology is expected to change production methods, the products themselves and the structure of the industries in the new economies. Hopefully, countries in the Middle-East, Latin America, Asia and Africa have already recognized the importance of  biotechnology's promise. In this sense, the importance of externalities which might affect the success or failure of these companies becomes an issue of paramount importance. In the present study, we will try to identify the main external factors which could lead in the success of  biotechnology firms in Iran. To do so, the research follows a qualitative research design to answer this main question. Based on our findings, critical success factors are categorized in the following categories: General Environment (GE), Political Position (PP), Economic Position (EP), and Market Position (MP).

Downloads

Download data is not yet available.

Article Details

Issue
Vol. 5 No. 1 (2014): Independent Journal of Management & Production
Section
Articles

1. Proposal of Policy for Free Access Periodics

Authors whom publish in this magazine should agree to the following terms:

a. Authors should keep the copyrights and grant to the magazine the right of the first publication, with the work simultaneously permitted under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 that allows the sharing of the work with recognition of the authorship of the work and initial publication in this magazine.

b. Authors should have authorization for assuming additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (e.g.: to publish in an institutional repository or as book chapter), with recognition of authorship and initial publication in this magazine.

c. Authors should have permission and should be stimulated to publish and to distribute its work online (e.g.: in institutional repositories or its personal page) to any point before or during the publishing process, since this can generate productive alterations, as well as increasing the impact and the citation of the published work (See The Effect of Free Access).

 

Proposal of Policy for Periodic that offer Postponed Free Access

Authors whom publish in this magazine should agree to the following terms:

 

a. Authors should keep the copyrights and grant to the magazine the right of the first publication, with the work simultaneously permitted under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 [SPECIFY TIME HERE] after the publication, allowing the sharing of the work with recognition of the authorship of the work and initial publication in this magazine.

 

b. Authors should have authorization for assuming additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (e.g.: to publish in institutional repository or as book chapter), with recognition of authorship and initial publication in this magazine.

 

c. Authors should have permission and should be stimulated to publish and to distribute its work online (e.g.: in institutional repositories or its personal page) to any point before or during the publishing process, since this can generate productive alterations, as well as increasing the impact and the citation of the published work (See The Effect of Free Access).


d. They allow some kind of open dissemination. Authors can disseminate their articles in open access, but with specific conditions imposed by the editor that are related to:
     Version of the article that can be deposited in the repository:
           Pre-print: before being reviewed by pairs.
           Post-print: once reviewed by pairs, which can be:
                  The version of the author that has been accepted for publication.
                  The editor's version, that is, the article published in the magazine.
           At which point the article can be made accessible in an open manner: before it is published in the magazine, immediately afterwards or if a period of seizure is required, which can range from six months to several years.
      Where to leave open: on the author's personal web page, only departmental websites, the repository of the institution, the file of the research funding agency, among others.

Author Biographies

Abdolreza Gholamali, University of Tehran

Abdolreza Gholamali is an instructor in Civil Aviation Technology Collage (CATC) and management universities. He Cooperates with private sector companies and SMEs in Iran as a Consultant in management systems. He has educated with Master of Art in Entrepreneurship Management (Business Creation) from University of Tehran Faculty of Entrepreneurship. He has studied on the causes of success and failure of Iranian SMEs. His researches focus on SMEs in tourism industry, media and biotechnology. He has also researched in growth strategies, internationalization, globalization of business, e-business, innovation and Entrepreneurship, and published some papers.

Sima Sarafi Zanjani, Islamic Azad University, Tehran

Sima Sarrafi Zanjani is a researcher in economics and media field. She studied literature and media in bachelor and master levels in two famous universities of Iran (Shahid Beheshti University and IAU) and passed the courses in A level. Her enthusiasm in study and job as a journalist caused that she had many international trips for comparing the ways of developing the society and business. She worked hardly for 20 years in various newspapers and recently was selected as a chief editor in Iran Daily economic and world economic news paper. Sarrafi Zanjani is a well known journalist who tries to help the society for standard behaviors in every aspect especially economic field. Sarrafi Zanjani wrote many articles in SME filed in Iran press. She was also awarded in reporting the worst problems in Iran business.
Crossref
Scopus
Google Scholar
Europe PMC

References

AUDRETSCH, D. B.; STEPHAN, P. E. (1996). Company-scientist locational links: The case of biotechnology. The American Economic Review, v. 86, n. 3, p. 641-652.

BECK, S. J.; LAUDICINA, R. J. (2001). Passing the torch: Mentoring the next generation of laboratory professionals. Clinical Laboratory Science, v. 14, n. 1, p. 33-37.

CARTER, C. R.; KALE, R.; GRIMM, C. M. (2000). Environmental purchasing and firm performance: an empirical investigation. Transportation Research Part E: Logistics and Transportation Review, v. 36, n. 3, p. 219-228.

CVILIKAS, A.; KARPAVIČIUS, T.; GATAUTIS, R. (2007). Application of systemic management conception to organization’s management decisions structuring. Engineering Economics, v. 4, n. 54, p. 44.

DARKE, P.; SHANKS, G.; BROADBENT, M. (1998). Successfully completing case study research: combining rigor, relevance and pragmatism. Information Systems Journal, n. 8, p. 273-289.

EISENHARDT, K. M. (1989). Building theories from case study research. Academy of management review, v. 14, n. 4, p. 532-550.

FÁRI M. G.; KRALOVÁNSZKY U. P. (2006). The founding father of biotechnology: Károly (Karl) Ereky. International Journal of Horticultural Science, v. 12, n. 1, p. 9-12.

FARSI, J. Y.; MODARRESI, M.; MOTEVASSELI, M.; SALAMZADEH, A. (2013). Institutional Factors Affecting Academic Entrepreneurship: The Case of University of Tehran. Economic Analysis, v. 46, n. 3/4, Forthcoming.

GEORGE, G.; ZAHRA, S. A.; WOOD, D. R. (2002). The effects of business–university alliances on innovative output and financial performance: a study of publicly traded biotechnology companies. Journal of Business Venturing, v. 17, n. 6, p. 577-609.

GREIF, K. F.; MERZ, J. F. (2007). Current Controversies in the Biological Sciences: Case Studies of Policy Challenges from New Technologies. MIT Press.

KAMERY, R. H. (2004). Employee Motivation as it Relates to Effectiveness, Efficiency, Productivity, and Performance. Academy of Legal, Ethical and Regulatory Issues, p. 139.

KOLLMER, H.; DOWLING, M. (2004). Licensing as a commercialisation strategy for new technology-based firms. Research Policy, v. 33, n. 8, p. 1141-1151.

LECHLER, T. (2001). Social interaction: A determinant of entrepreneurial team venture success. Small Business Economics, v. 16, n. 4, p. 263-278.

LEVITAS, E.; MCFADYEN, M. (2009). Managing liquidity in research‐intensive firms: signaling and cash flow effects of patents and alliance activities. Strategic Management Journal, v. 30, n. 6, p. 659-678.

MAHBOUDI, F.; HAMEDIFAR, H.; AGHAJANI, H. (2012). Medical Biotechnology Trends and Achievements in Iran. Avicenna Journal of Medical Biotechnology, v. 4, n. 4, p. 200-205.

MALO, S.; NORUS, J. (2009). Growth dynamics of dedicated biotechnology firms in transition economies. Evidence from the Baltic countries and Poland. Entrepreneurship & Regional Development, v. 21, n. 5/6, p. 481-502.

MANGEMATIN, V.; LEMARIÉ, S.; BOISSIN, J. P.; CATHERINE, D.; COROLLEUR, F.; CORONINI, R.; TROMMETTER, M. (2003). Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France. Research Policy, v. 32, n. 4, p. 621-638.

Martin, J. (1992). Cultures in organizations: Three perspectives. Oxford University Press, USA.

MROCZKOWSKI, T. (2010). Key Success Factors in Polish Biotech Ventures. Studia Ekonomiczne, n. 1, p. 57-80.

MROCZKOWSKI, T.; ELMS, H. (2009). Tracking progress: Two approaches to biotechnology development–Cases from Central Europe. Journal of Commercial Biotechnology, v. 15, n. 3, p. 227-235.

NIOSI, J.; BAS, T. G. (2001). The competencies of regions–Canada's clusters in biotechnology. Small Business Economics, v. 17, n. 1, p. 31-42.

PERSAUD, A. (2001). The knowledge gap. Foreign Affairs, p. 107-117.

POWELL, W. W. (1996). Inter-organizational collaboration in the biotechnology industry. Journal of Institutional and Theoretical Economics (JITE)/Zeitschrift für die gesamte Staatswissenschaft, p. 197-215.

REYMOND, M. A.; STEINERT, R.; ESCOURROU, J.; FOURTANIER, G. (2002). Ethical, legal and economic issues raised by the use of human tissue in postgenomic research. Digestive Diseases, v. 20, n. 3/4, p. 257-265.

ROCKHART, J. F. (1979). Critical Success Factors. Harvard Business Review, March-April, p. 81-91.

SALAMZADEH, A.; SALAMZADEH, Y.; DARAEI, M. (2011). Toward a systematic framework for an Entrepreneurial University: A study in Iranian context with IPOO Model. Global Business and Management Research: An International Journal, v. 3, n. 1, p. 31-37.

SHANKS, G.; PARR, A.; H. U. B.; CORBITT, B.; THANASANKIT, T.; SEDDON, P. (2000, July). Differences in critical success factors in ERP systems implementation in Australia and China: a cultural analysis. In Proceedings of the 8th European Conference on Information Systems (v. 2000, p. 537-544). Cairo University.

SOOREH, L. K.; SALAMZADEH, A.; SAFARZADEH, H.; SALAMZADEH, Y. (2011). Defining and Measuring Entrepreneurial Universities: A Study in Iranian context using Importance-Performance Analysis and TOPSIS Technique. Global Business and Management Research: An International Journal, v. 3, n. 2, p. 182-200.

STEVENS, R. E.; LOUDON, D. L.; WILLIAMSON, S. (1998). Getting it done: achieving law firm objectives through the development of effective marketing strategies. Journal of Professional Services Marketing, v. 17, n. 1, p. 105-118.

SVENSSON, T. G. (1986). Ethnopolitics among the Sámi in Scandinavia: A Basic Strategy toward Local Autonomy. Arctic, p. 208-215.

TANHA, D.; SALAMZADEH, A.; ALLAHIAN, Z.; SALAMZADEH, Y. (2011). Commercialization of University Research and Innovations in Iran: Obstacles and Solutions. Journal of Knowledge Management, Economics, and Information Technology, v. 1, n. 7, p. 126-146.

VANDERBYL, S.; KOBELAK, S. (2007). Critical success factors for biotechnology industry in Canada. Journal of Commercial Biotechnology, v. 13, n. 2, p. 68-77.

YIN, R. (1989). Case Study Research: Design and Methods. San Francisco, CA: Sage.

YOUNG, F. E. (1986). Biotechnology: the view from the FDA. Health Matrix, v. 4, n. 3, p. 10-15.

فروشگاه اینترنتی ویزای استارتاپ luxury gifts